Our Clinical Trials

Our clinical trials are a crucial step in developing transformative medicines. They have already enrolled thousands of patients worldwide.

TARGETING MET clinical trials now enrolling

Targeting MET

Are you interested in learning more about a clinical trial program investigating the inhibition of oncogenic signaling caused by MET (gene) alterations?

LEARN MORE ABOUT OUR CLINICAL TRIALS
DDRiver clinical trial program

DDRiver

Are you interested in learning more about a clinical trial program investigating the potential anticancer effect of inhibiting the DNA damage response (DDR) pathway?

LEARN MORE ABOUT OUR CLINICAL TRIALS
DDRiver clinical trial program

TrilynX

Are you interested in learning more about a clinical trial investigating the potential to enhance the activity of definitive therapy for LA SCCHN through antagonism of Inhibitor of Apoptosis Proteins (IAP)?

LEARN MORE ABOUT THIS CLINICAL TRIAL